SFM
NKTR icon

Systematic Financial Management’s Nektar Therapeutics NKTR Stock Holding History

Systematic Financial Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3
Closed -$1K – 661
2018
Q4 		$1K Sell
3
-12,950
-100% -$7.82M ﹤0.01% 633
2018
Q3 		$11.8M Sell
12,953
-1,447
-10% -$1.24M 0.29% 138
2018
Q2 		$10.5M Buy
14,400
+3,820
+36% +$4.4M 0.26% 159
2018
Q1 		$16.9M Sell
10,580
-12,114
-53% -$15.6M 0.37% 92
2017
Q4 		$20.3M Sell
22,694
-27,038
-54% -$16M 0.41% 76
2017
Q3 		$17.9M Buy
49,732
+863
+2% +$270K 0.36% 93
2017
Q2 		$14.3M Buy
48,869
+425
+0.9% +$123K 0.26% 114
2017
Q1 		$17.1M Sell
48,444
-1,238
-2% -$278K 0.3% 99
2016
Q4 		$9.14M Buy
49,682
+4,781
+11% +$972K 0.15% 199
2016
Q3 		$11.6M Sell
44,901
-10,738
-19% -$2.76M 0.16% 163
2016
Q2 		$11.9M Sell
55,639
-1,760
-3% -$393K 0.16% 159
2016
Q1 		$11.8M Sell
57,399
-1,629
-3% -$313K 0.15% 162
2015
Q4 		$14.9M Sell
59,028
-11,068
-16% -$2.28M 0.16% 121
2015
Q3 		$11.5M Sell
70,096
-4,877
-7% -$863K 0.12% 191
2015
Q2 		$14.1M Buy
74,973
+2,368
+3% +$408K 0.12% 196
2015
Q1 		$12M Sell
72,605
-184
-0.3% -$37.8K 0.09% 246
2014
Q4 		$16.9M Sell
72,789
-9,050
-11% -$1.93M 0.13% 166
2014
Q3 		$14.8M Sell
81,839
-11,244
-12% -$2.15M 0.11% 191
2014
Q2 		$17.9M Buy
93,083
+2,746
+3% +$486K 0.12% 186
2014
Q1 		$16.4M Sell
90,337
-18,958
-17% -$3.75M 0.11% 193
2013
Q4 		$18.6M Sell
109,295
-2,164
-2% -$349K 0.14% 169
2013
Q3 		$17.5M Buy
111,459
+15,454
+16% +$2.86M 0.14% 159
2013
Q2 		$16.6M Buy
+96,005
New +$14.7M 0.14% 159

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Systematic Financial Management's NKTR Position: Q1 2019 in Review

Systematic Financial Management sold out of Nektar Therapeutics (NKTR) in Q1 2019, closing a stake of 3 shares — an estimated $1K sold.

Systematic Financial Management first reported a position in NKTR in Q2 2013 and held it in 23 quarters. The position peaked at $20.3M in Q4 2017. 350 funds tracked by Wall St. Rank hold NKTR as of Q1 2019.

  • Systematic Financial Management reported no remaining Nektar Therapeutics position as of Q1 2019 after selling out during the quarter.
  • Systematic Financial Management sold 3 Nektar Therapeutics shares in Q1 2019, an estimated $1K.
  • Systematic Financial Management first reported a position in Nektar Therapeutics in Q2 2013 and held it in 23 quarters.
  • Systematic Financial Management's Nektar Therapeutics position peaked at $20.3M in Q4 2017.
  • 350 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2019.

Based on Systematic Financial Management's 13F filing for Q1 2019, filed 3 May 2019.